(Q30274942)

8 July 2018

title

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia (English)

1 reference

8 July 2018

chronic myelomonocytic leukemia

main subject

1 reference

11

1 reference

8 July 2018

Aaron T Gerds

19

1 reference

8 July 2018

Jorge Eduardo Cortes

37

Jorge Cortes

1 reference

8 July 2018

21

Martin Tallman

1 reference

8 July 2018

8

David Rizzieri

1 reference

8 July 2018

Mark R Litzow

28

Mark R Litzow

1 reference

8 July 2018

Peter H. Wiernik

35

Peter H Wiernik

1 reference

8 July 2018

Uday R Popat

41

Uday Popat

1 reference

8 July 2018

author name string

Hien Duong Liu

1

1 reference

8 July 2018

Kwang Woo Ahn

2

1 reference

8 July 2018

Zhen-Huan Hu

3

1 reference

8 July 2018

Mehdi Hamadani

4

1 reference

8 July 2018

Taiga Nishihori

5

1 reference

8 July 2018

Baldeep Wirk

6

1 reference

8 July 2018

Amer Beitinjaneh

7

1 reference

8 July 2018

Michael R Grunwald

9

1 reference

8 July 2018

Mitchell Sabloff

10

1 reference

8 July 2018

Ashish Bajel

12

1 reference

8 July 2018

Christopher Bredeson

13

1 reference

8 July 2018

Andrew Daly

14

1 reference

8 July 2018

Yoshihiro Inamoto

15

1 reference

8 July 2018

Navneet Majhail

16

1 reference

8 July 2018

Ayman Saad

17

1 reference

8 July 2018

Vikas Gupta

18

1 reference

8 July 2018

Adriana Malone

20

1 reference

8 July 2018

Ran Reshef

22

1 reference

8 July 2018

David I Marks

23

1 reference

8 July 2018

Edward Copelan

24

1 reference

8 July 2018

Usama Gergis

25

1 reference

8 July 2018

Mary Lynn Savoie

26

1 reference

8 July 2018

Celalettin Ustun

27

1 reference

8 July 2018

Jean-Yves Cahn

29

1 reference

8 July 2018

Tamila Kindwall-Keller

30

1 reference

8 July 2018

Gorgun Akpek

31

1 reference

8 July 2018

Bipin N Savani

32

1 reference

8 July 2018

Mahmoud Aljurf

33

1 reference

8 July 2018

Jacob M Rowe

34

1 reference

8 July 2018

Jack W Hsu

36

1 reference

8 July 2018

Matt Kalaycio

38

1 reference

8 July 2018

Richard Maziarz

39

1 reference

8 July 2018

Ronald Sobecks

40

1 reference

8 July 2018

Edwin Alyea

42

1 reference

8 July 2018

Wael Saber

43

1 reference

8 July 2018

publication date

20 January 2017

1 reference

8 July 2018

Biology of Blood and Marrow Transplantation

published in

1 reference

8 July 2018

volume

23

1 reference

8 July 2018

issue

5

1 reference

8 July 2018

page(s)

767-775

1 reference

8 July 2018

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

The World Health Organization (WHO) classification of the myeloid neoplasms

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

International scoring system for evaluating prognosis in myelodysplastic syndromes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Activity of azacitidine in chronic myelomonocytic leukemia.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Risk assessment in chronic myelomonocytic leukemia (CMML).

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5590102

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

26 November 2018

1 reference

12 December 2020

Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

12 December 2020

New prognostic parameters for chronic myelomonocytic leukemia

1 reference

12 December 2020

Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation

1 reference

12 December 2020

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

12 December 2020

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

1 reference

12 December 2020

10.1016/J.BBMT.2017.01.078

Identifiers

DOI

1 reference

8 July 2018

PMCID

5590102

1 reference

8 July 2018

PubMed ID

28115276

1 reference

8 July 2018